Lactulose Breath Testing Predicts Response to Rifaximin for Cardinal Irritable Bowel Syndrome With Diarrhea (IBS-D)

被引：0
|
作者：
Rezaie, Ali [1 ]
Heimanson, Zeev [2 ]
Israel, Robert J. [2 ]
McCallum, Richard [3 ]
Pimentel, Mark [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Salix Pharmaceut, Bridgewater, NJ USA
[3] Texas Tech Univ, Hlth Sci Ctr, El Paso, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
468
引用
收藏
页码：S269 / S269
页数：1
相关论文
共 50 条
  • [1] Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
    Rezaie, Ali
    Heimanson, Zeev
    McCallum, Richard
    Pimentel, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (12): : 1886 - 1893
  • [2] Impact of Colonoscopy Timing on Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
    Lacy, Brian E.
    Lembo, Anthony
    Pimental, Mark
    Heimanson, Zeev
    Cash, Brooks D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S295 - S295
  • [3] Characterization of Abdominal Pain Response to Rifaximin in Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D), by Baseline Pain Severity
    Lembo, Anthony
    Heimanson, Zeev
    Cash, Brooks D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S251 - S251
  • [4] Lack of Utility of Lactulose Breath Testing in the Irritable Bowel Syndrome (IBS)
    Sandhu, Davinder K.
    Talley, Nicholas J.
    Locke, G. Richard
    Zinsmeister, Alan R.
    Sandberg, Rodney
    Saito, Yuri A.
    GASTROENTEROLOGY, 2009, 136 (05) : A484 - A484
  • [5] EFFICACY OF RIFAXIMIN IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND PRIOR USE OF IBS MEDICATIONS
    Lembo, Anthony J.
    Rao, Satish S.
    Rezaie, Ali
    Heimanson, Zeev
    Pimentel, Mark
    GASTROENTEROLOGY, 2018, 154 (06) : S499 - S499
  • [6] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin
    Lembo, Anthony J.
    Heimanson, Zeev
    Pimentel, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236
  • [7] CHARACTERIZATION OF ABDOMINAL PAIN RESPONSE TO RIFAXIMIN IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D), BY BASELINE PAIN SEVERITY
    Lembo, Anthony
    Heimanson, Zeev
    Cash, Brooks D.
    GASTROENTEROLOGY, 2019, 156 (06) : S775 - S775
  • [8] RIFAXIMIN IS EFFICACIOUS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULTS PREVIOUSLY TREATED WITH OTHER IBS MEDICATIONS
    Rao, Satish S.
    Schoenfeld, Philip S.
    Heimanson, Zeev
    Rezaie, Ali
    Lacy, Brian E.
    GASTROENTEROLOGY, 2020, 158 (06) : S852 - S852
  • [9] Use of Lactulose Breath Tests to Predict Response to Rifaximin in Irritable Bowel Syndrome With Diarrhea: The Positives and Negatives
    Black, Christopher J.
    Ford, Alexander C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (06): : 955 - 956
  • [10] Lactulose Breath Testing and Irritable Bowel Syndrome Response
    Jones, Michael P.
    Bratten, Jason
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (10): : 2653 - 2654
12345